Outcome MeasureCognition
AISRS
Adult ADHD Investigator Symptom Rating Scale
1 Paper in Blossom
Outcome Data Across Studies
Reported results for AISRS across 1 study with quantitative data.
| SD | ||||||
|---|---|---|---|---|---|---|
| Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial 2025Primary | MM-120(experimental) | 0 | 27 | 37.0 | 6.0 | — |
| Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial 2025Primary | Placebo(inactive) | 0 | 26 | 36.0 | 5.0 | — |
| Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial 2025Primary | MM-120(experimental) | 42 | — | -7.1Δ | — | — |
| Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults A Randomized Clinical Trial 2025Primary | Placebo(inactive) | 42 | — | -8.9Δ | — | — |
Papers Using AISRS
Quick Facts
- Full Name
- Adult ADHD Investigator Symptom Rating Scale
- Domain
- Cognition
- Papers Indexed
- 1
- Score Range
- 0–54
- Interpretation
- Lower = better